We are live on ! Find out more
CADL icon

Candel Therapeutics
CADL

20 hedge funds and large institutions have $54.4M invested in Candel Therapeutics in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

67% more funds holding

Funds holding: 12 → 20 (+8)

7.21% more ownership

Funds ownership: 17.02% → 24.23% (+7.2%)

3% more capital invested

Capital invested by funds: $52.9M → $54.4M (+$1.41M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
20
Holders Change
+8
Holders Change %
+66.67%
% of All Funds
0.31%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
5
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.96M
2
BlackRock
BlackRock
New York
+$896K
3
6CM
683 Capital Management
New York
+$397K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$368K
5
Northern Trust
Northern Trust
Illinois
+$131K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.3M
2
CCM
CAAS Capital Management
New York
-$542K
3
Wells Fargo
Wells Fargo
California
-$12K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$17.7M -$2.3M -237,158 -9%
NV
2
Northpond Ventures
Maryland
$15.1M +$18.8M +1,935,215 New
Franklin Resources
3
Franklin Resources
California
$8.8M – – –
SCV
4
Sands Capital Ventures
Virginia
$6.35M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$3.25M +$1.96M +201,773 +94%
BlackRock
6
BlackRock
New York
$896K +$896K +92,288 +413%
WP
7
Woodline Partners
California
$782K – – –
Geode Capital Management
8
Geode Capital Management
Massachusetts
$455K +$368K +37,890 +186%
6CM
9
683 Capital Management
New York
$320K +$397K +40,929 New
State Street
10
State Street
Massachusetts
$208K – – –
Northern Trust
11
Northern Trust
Illinois
$105K +$131K +13,455 New
Millennium Management
12
Millennium Management
New York
$102K +$23.9K +2,460 +23%
Goldman Sachs
13
Goldman Sachs
New York
$83K +$103K +10,593 New
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$79K +$98.3K +10,122 New
Morgan Stanley
15
Morgan Stanley
New York
$36K +$45.8K +4,722 New
UBS Group
16
UBS Group
Switzerland
$34K +$14K +1,447 +48%
JP Morgan Chase
17
JP Morgan Chase
New York
$20K +$24.6K +2,529 New
Bank of America
18
Bank of America
North Carolina
$8K +$10.6K +1,088 New
Citigroup
19
Citigroup
New York
$7K +$8.41K +866 New
HNWAG
20
High Net Worth Advisory Group
Florida
$2K +$2.91K +300 New
CCM
21
CAAS Capital Management
New York
– -$542K -50,000 Closed
Wells Fargo
22
Wells Fargo
California
– -$12K -1,054 Closed

CADL Hedge Fund Activity: Q4 2021 in Review

20 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Candel Therapeutics (CADL) for Q4 2021, worth a combined $54.4M — up 2.7% from $52.9M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new CADL positions and 2 closed out — a net gain of 8 holders — while 5 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.96M. The largest seller was Fidelity Investments, cutting an estimated $2.3M.

  • 20 institutional investors held Candel Therapeutics (CADL) as of Q4 2021, up from 12 in Q3 2021.
  • Funds reported $54.4M of Candel Therapeutics stock for Q4 2021, up 2.7% quarter-over-quarter.
  • 10 funds opened new Candel Therapeutics positions in Q4 2021 and 2 closed out, a net change of +8 holders.
  • The largest Candel Therapeutics buyer in Q4 2021 was Vanguard Group, an estimated $1.96M added.
  • The largest Candel Therapeutics seller in Q4 2021 was Fidelity Investments, an estimated $2.3M sold.

Based on aggregated 13F filings for Q4 2021.